Literature DB >> 6691335

Disability days associated with detection and treatment in a hypertension control program.

B F Polk, L C Harlan, S P Cooper, M Stromer, J Ignatius, H Mull, T P Blaszkowski.   

Abstract

Labeling individuals as hypertensive has been associated with increased absenteeism from work. Distributions of disability days were compared for the years before and after screening for hypertension among 10,049 participants in a clinical trial of intensive antihypertensive therapy. Stepped care participants attended special clinics and referred care participants returned to their usual sources of medical care. For those unaware of their hypertension at screening, disability days increased between baseline and one year among referred care (n = 1805), while there was no change among stepped care (n = 1842) participants. Neither referred care (n = 1868) nor stepped care (n = 1906) participants who were aware but untreated at baseline reported a change in disability days over the following year. For those aware and treated at baseline, there was no change in disability days in referred care (n = 1275), but a decrease was reported in stepped care (n = 1353). Further descriptive analyses suggest that neither labeling alone nor treatment alone was associated with increased absenteeism. However, detection and treatment were associated with increased absenteeism among newly diagnosed referred care hypertensives, while management of previously treated hypertensives in stepped care clinics was associated with reduced absenteeism. Because these latter comparisons are made between groups stratified on a postrandomization variable, selection bias is possible and interpretations must be made with caution.

Entities:  

Mesh:

Year:  1984        PMID: 6691335     DOI: 10.1093/oxfordjournals.aje.a113724

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Diagnosis and treatment of high blood pressure. New directions and new approaches: 1999 Canadian recommendations for management of hypertension.

Authors:  R J Petrella
Journal:  Can Fam Physician       Date:  2000-07       Impact factor: 3.275

Review 2.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

3.  Psychological consequences of hypercholesterolaemia.

Authors:  J Barlow
Journal:  Br J Gen Pract       Date:  1993-10       Impact factor: 5.386

4.  Hypertension and sickness absence: the role of perceived symptoms.

Authors:  S Melamed; P Froom; M S Green
Journal:  J Behav Med       Date:  1997-10

5.  Report of the Canadian Hypertension Society's consensus conference on the management of mild hypertension.

Authors:  A G Logan
Journal:  Can Med Assoc J       Date:  1984-11-01       Impact factor: 8.262

6.  Job absenteeism and arterial hypertension: results of a hypertension control program.

Authors:  S Ruiz de la Fuente Tirado; P Cortina Greus; J L Alfonso Sanchez; C Saiz Sanchez; A Sabater Pons; J I Gonzalez Arraez; C Cortes Vizcaino
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

7.  Health-related quality of life in cardiac patients with dyslipidemia and hypertension.

Authors:  Lyne Lalonde; Annette O'Connor; Lawrence Joseph; Steven A Grover
Journal:  Qual Life Res       Date:  2004-05       Impact factor: 4.147

8.  The association between hypertension treatment, control, and functional status.

Authors:  D S Siscovick; D S Strogatz; S W Fletcher; B Leake; R H Brook
Journal:  J Gen Intern Med       Date:  1987 Nov-Dec       Impact factor: 5.128

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.